This program addresses the massive problem of iatrogenic injury and death, the inadequacy of the law’s conventional response, and several of the more innovative approaches the law might be taking in the future to raise the level of patient safety. Those more innovative approaches will be more regulatory than litigative.
Three areas to be discussed are new incentives for investment in safety, error reporting, and engaged surveillance.
Learning Objectives:
• Acquire a more complete picture of the nature and extent of the problem of iatrogenic harm.
• Understand the limited efficacy of malpractice liability in encouraging prevention of harm.
• Learn about new incentives (existing and proposed) to create a business case for patient safety.
• Learn about failings of error reporting regimes.
• Learn about engaged surveillance.
AI agents — autonomous systems capable of planning, deciding, and acting independently across ...
As the largest purchaser of goods and services in the world, the United States Government requires f...
"Artificial Intelligence and the Practice of Law" (updated through 2026), is a 50-slide primer desig...
Objections are among the most powerful — and most misunderstood — tools in a trial lawye...
During this course, you will learn about best practices and strategies for retaining intellectual pr...
This program will discuss how to design and implement legally sound diversity, equity, and inclusion...
This presentation provides a basic overview of AI governance in the United States for in-house attor...
This course on trade secrets litigation provides real-world best practices through all key stages of...
Perfectionism is often rewarded in the legal profession. It drives attention to detail, thorough pre...
The Twelfth Juror: Lessons on Jury Selection from a Trial Lawyer’s Novel and a Trial Consultan...